4.5 Article

The analysis of C9orf72 repeat expansions in a large series of clinically and pathologically diagnosed cases with atypical parkinsonism

期刊

NEUROBIOLOGY OF AGING
卷 36, 期 2, 页码 -

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2014.08.024

关键词

C9orf72; Parkinsonism; Multiple system atrophy (MSA); Progressive supranuclear palsy (PSP); Corticobasal degeneration (CBD) and corticobasal syndrome (CBS)

资金

  1. Medical Research Council [G0802760]
  2. Wellcome Trust/MRC Joint Call in Neurodegeneration award [WT089698]
  3. Brain Research Trust
  4. National Organization for Rare Disorders
  5. MSA Trust
  6. National Institutes of Health (NIH) dystonia Coalition from ORDR in National Center for Advancing Translational Sciences (NCATS) [NS065701]
  7. National Institutes of Neurological disorders and stroke (NINDS) as part of the NIH Rare Diseases Clinical Research Network (RDCRN)
  8. Dystonia medical research foundation (DMRF)
  9. National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre (BRC)
  10. Reta Lila Weston Trust for Medical Research
  11. MRC [MC_G1000735, G0802760, MR/J004758/1, G1001253, G108/638, G0501560] Funding Source: UKRI

向作者/读者索取更多资源

A GGGGCC repeat expansion in the C9orf72 gene was recently identified as a major cause of familial and sporadic amyotrophic lateral sclerosis and frontotemporal dementia. There is suggestion that these expansions may be a rare cause of parkinsonian disorders such as progressive supranuclear palsy (PSP), multiple system atrophy (MSA), and corticobasal degeneration (CBD). Screening the C9orf72 gene in 37 patients with features of corticobasal syndrome (CBS) detected an expansion in 3 patients, confirmed by Southern blotting. In a series of 22 patients with clinically diagnosed PSP, we found 1 patient with an intermediate repeat length. We also screened for the C9orf72 expansion in a large series of neuro-pathologically confirmed samples with MSA (n = 96), PSP (n = 177), and CBD (n = 18). Patients were found with no more than 22 GGGGCC repeats. Although these results still need to be confirmed in a larger cohort of CBS and/or CBD patients, these data suggest that in the presence of a family history and/or motor neuron disease features, patients with CBS or clinical PSP should be screened for the C9orf72 repeat expansion. In addition, we confirm that the C9orf72 expansions are not associated with pathologically confirmed MSA, PSP, or CBD in a large series of cases. (C) 2015 The Authors. Published by Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据